MNMD Mind Medicine (MindMed) Inc

Price (delayed)

$5.97

Market cap

$449.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.54

Enterprise value

$198.06M

Highlights
The company's EPS rose by 37% YoY and by 23% QoQ
MNMD's quick ratio has soared by 128% YoY but it is down by 21% from the previous quarter
The debt has surged by 55% year-on-year but it has declined by 10% since the previous quarter
The net income has declined by 14% year-on-year and by 11% since the previous quarter
Mind Medicine (MindMed)'s equity has decreased by 8% from the previous quarter

Key stats

What are the main financial stats of MNMD
Market
Shares outstanding
75.37M
Market cap
$449.95M
Enterprise value
$198.06M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.81
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$103.92M
Net income
-$108.68M
EBIT
-$106.4M
EBITDA
-$105.87M
Free cash flow
-$79.13M
Per share
EPS
-$1.54
EPS diluted
-$1.54
Free cash flow per share
-$1.12
Book value per share
$3.29
Revenue per share
$0
TBVPS
$4.01
Balance sheet
Total assets
$302.15M
Total liabilities
$60.7M
Debt
$21.85M
Equity
$241.45M
Working capital
$242.77M
Liquidity
Debt to equity
0.09
Current ratio
7.25
Quick ratio
7.05
Net debt/EBITDA
2.38
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-37.3%
Return on equity
-48.2%
Return on invested capital
N/A
Return on capital employed
-40.4%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MNMD stock price

How has the Mind Medicine (MindMed) stock price performed over time
Intraday
7.76%
1 week
-9.27%
1 month
-11.16%
1 year
-39.39%
YTD
-14.22%
QTD
2.05%

Financial performance

How have Mind Medicine (MindMed)'s revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$103.92M
Net income
-$108.68M
Gross margin
N/A
Net margin
N/A
The net income has declined by 14% year-on-year and by 11% since the previous quarter
The operating income has declined by 11% since the previous quarter and by 11% year-on-year

Growth

What is Mind Medicine (MindMed)'s growth rate over time

Valuation

What is Mind Medicine (MindMed) stock price valuation
P/E
N/A
P/B
1.81
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 37% YoY and by 23% QoQ
The P/B is 46% below the 5-year quarterly average of 3.1 and 20% below the last 4 quarters average of 2.1
Mind Medicine (MindMed)'s equity has decreased by 8% from the previous quarter

Efficiency

How efficient is Mind Medicine (MindMed) business performance
The ROE is up by 48% year-on-year and by 9% since the previous quarter
MNMD's ROA is up by 45% YoY and by 6% from the previous quarter

Dividends

What is MNMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MNMD.

Financial health

How did Mind Medicine (MindMed) financials performed over time
Mind Medicine (MindMed)'s total assets has soared by 143% YoY but it has decreased by 6% from the previous quarter
MNMD's quick ratio has soared by 128% YoY but it is down by 21% from the previous quarter
The debt is 91% smaller than the equity
The debt has surged by 55% year-on-year but it has declined by 10% since the previous quarter
Mind Medicine (MindMed)'s debt to equity has plunged by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.